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Adipose differentiation-related protein (ADRP) is localized to
lipid droplets in most mammalian cells. ADRP, proposed to regu-
late fatty acid mobilization and lipid droplet formation, is linked to
lipid accumulation in foam cells of human atherosclerotic lesions.
In this report, we show that ADRP protein accumulates in Chinese
hamster ovary fibroblastic cells cultured in the presence of oleic
acid but is destabilized when fatty acid sources are removed from
culture serum. The latter effect was blocked by the proteasome
inhibitor MG132, whereas inhibitors of other proteolytic processes
were ineffective. Pulse-chase experiments confirmed that ADRP
degradation is inhibited by MG132. Conditions that stimulate
ADRP degradation also promoted the covalent modification of
ADRP by ubiquitin, whereas the addition of oleic acid to culture
media, which promotes triacylglycerol deposition, blunted the
appearance of ubiquitinated-ADRP. Treatment with MG132
increased the levels of ADRP associated with lipid droplets, as well
as throughout the cytosol. Finally, we demonstrate that the disap-
pearance of ADRP protein after the onset of perilipin expression
during adipocyte differentiation is due to degradation by protea-
somes Thus, proteolytic degradation of ADRP mediated through
the ubiquitin/proteasome pathway appears to be a major mode for
the post-translational regulation of ADRP.
Intracellular neutral lipid storage droplets in eukaryotes are ubiqui-
tous cellular organelles required for membrane biosynthesis, choles-
terol metabolism, and energy balance (1, 2). Lipid droplets contain a
triacylglycerol (TAG)6 and cholesterol ester core surrounded by a phos-
pholipidmonolayer (3). Several related proteins localize to the surface of
lipid droplets (4), including perilipin (5–8), adipose differentiation-re-
lated protein (ADRP) (9), TIP47 (10, 11), a putative cargo protein for the
mannose 6-phosphate receptors (12), and S3–12 (13). These proteins
share sequence homology within their PAT (perilipin/ADRP/TIP47)
domains (4, 11, 14) and are derived from a common ancestral gene (15).
The localization to lipid droplets suggests that PAT proteins play a
fundamental role in lipid metabolism (4, 16). To date, perilipin is the
only family member for which a function in lipid metabolism has been
firmly established (17), for review see Tansey et al. (18). Lipolysis in
adipocytes is governed primarily by a protein kinase A-mediated reac-
tion. Non-protein kinase A-phosphorylated perilipin protects TAG
from hydrolysis and thus promotes TAG storage (19, 20). Indeed perili-
pin-null mice have reduced adipose TAG storage (21, 22). However
phosphorylation of perilipin is required for the translocation of hor-
mone-sensitive lipase from the cytosol to the lipid droplet surface (17).
Because migration of hormone-sensitive lipase largely determines lipo-
lytic activation in adipocytes, stimulation of lipolysis is strongly blunted
in isolated primary adipocytes that lack perilipin or in whole perilipin-
null animals (21).
ADRP, also termed adipophilin, is a 47-kDa protein that shares
sequence similarity with perilipin (4). Unlike perilipin which is specific
for adipocytes and steroidogenic cells (5–7), ADRP is expressed inmost
tissues (9, 23, 24). ADRP is suggested to selectively increase the uptake
of long chain fatty acids and has a possible role in fatty acid transport
(25–27). Cells culturedwith fatty acidsmay have elevatedADRPmRNA
and protein expression (26, 27). In lung tissue, the developmental
expression pattern of ADRPmRNA and protein parallel TAG accumu-
lation (28). ADRP not only serves as a sensitive marker of lipid accumu-
lation (23, 29) but also has been reported to stimulate lipid accumulation
and lipid droplet formation in murine fibroblasts (30). A recent study
has revealed that ADRP mRNA is induced in human monocytes or
macrophages by either oxidized (31) or enzymatically modified (29) low
density lipoprotein and is highly expressed in a subset of lipid-rich foam
cells of human atherosclerotic lesions (31). By contrast, perilipinmRNA
is induced in foam cells of ruptured, but not of stable, human athero-
sclerotic plaques (32). Thus, the lipid droplet-associated proteins such
as ADRP and perilipin are likely potential regulators for lipid accumu-
lation of foam cells and destabilization of atherosclerotic plaque.
Although the PAT family proteins appear to play important roles in
lipid metabolism, there are few studies on the regulation of these pro-
teins; most available evidence points toward a post-translational regu-
lation ofADRP.The ubiquitin/proteasomepathway is a potentialmech-
anism for such regulation. Ubiquitin is an 8-kDa peptide of 76 amino
acids that is ubiquitous in eukaryotes. Typically, ubiquitin or a polyu-
biquitin chain is covalently conjugatedwith the targeted protein to form
polyubiquitinated protein complexes, which are delivered to and
degraded by the 26 S proteasome, a 2000-kDa ATP-dependent proteo-
lytic particle (33–35). If proteins fold improperly or form incorrect oli-
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gomeric structures, they may become conjugated to ubiquitin and pro-
teasomally degraded (33, 35). In the cellular response to environmental
changes, the ubiquitin/proteasome system has been shown to regulate
degradation of transcription factors, cell cycle proteins, tumor suppres-
sors, and cell surface receptors, as well as proteins that are damaged or
improperly localized (34). In this study, we report that a major mode for
the post-translational regulation of ADRP is degradation via the ubiq-
uitin/proteasome pathway.
EXPERIMENTAL PROCEDURES
Reagents—Unless otherwise noted, all chemical reagents were
obtained from Sigma. Proteasome or protease inhibitors MG132, lacta-
cystin, ALLN, calpeptin, and leupeptin were purchased from Calbio-
chem. Geneticin (G418) and DNA transfection reagents came from
Invitrogen. [35S]Methionine and an enhanced chemiluminescence
(ECL) detection kit were products of Amersham Biosciences. Methi-
onine-free DMEM is a product of BioFluids (Rockville,MD). Rabbit and
goat anti-mouse ADRP polyclonal sera were raised against a peptide
composed of the N-terminal 26 amino acid residues of murine ADRP.
Rabbit anti-ubiquitin antibody, agarose-conjugated protein A/G plus
mixture, and horseradish peroxidase-conjugated IgG were obtained
from Santa Cruz Biotechnology. Fluorescein isothiocyanate-conjugated
donkey anti-rabbit IgGwere purchased from Jackson Immunoresearch.
Cells Culture and Expression of ADRP in CHO Cells—Chinese ham-
ster ovary fibroblastic cells (CHO-K1, ATTC) were maintained in F12
medium (Invitrogen) containing 10% fetal calf serum (FCS), 100
units/ml penicillin, and 100 units/ml streptomycin at 37 °C in an atmo-
sphere of 5%CO2. Full-lengthmouseADRP cDNAwas subcloned in the
pcDNA3.1 vector and transfected into CHO cells using the Lipo-
fectamine Plus reagent (Invitrogen). After selection in 1500g/mlG418
(Invitrogen) for four generations, cells that stably expressed ADRP
(CHO-ADRP) were maintained in 10% FCS-F12 medium in the pres-
ence of 300 g/ml G418. For transient ADRP expression, CHO cells
were infectedwith a recombinant adenovirus-expressingmurine ADRP
(Ad-ADRP). This vector was constructed according to a previously
described method (17). For lipid loading, oleic acid was added to the
culture medium at 400mol as a 5:1 molar complex with bovine serum
albumin. For delipidation experiments, cells were cultured in medium
containing 10% charcoal-delipidated FCS (Sigma).
Immunoblot Analysis—Cells were washed twice, lysed in sample
buffer, diluted 1:1 with 2 SDS loading buffer, and heated to95 °C for
5 min. Equivalent amounts of protein were loaded, separated by 10%
SDS-PAGE, and transferred to nitrocellulose membranes. The mem-
brane was blocked using 5% nonfat dry milk in TBS buffer containing
150 mM NaCl, 0.05% Tween 20, and 20 mM Tris-HCl, pH 7.2, and
incubated for 1 h with primary antibodies against ADRP followed by
incubation for 1 h with specific secondary antibodies conjugated to
horseradish peroxidase. Blots were developed using an enhanced
chemiluminescence (ECL) detection kit.
Northern Blot Analysis—CHO cells were grown to 80% confluence,
and total cellular RNAwas extracted using TRIzol reagent (Invitrogen).
Thirty g of total RNA was loaded in each lane, separated in 1% form-
aldehyde denaturing agarose gel, and transferred to nylon membranes.
32P-LabeledADRP cDNAprobewas preparedwith the RediprimeDNA
random labeling system (Amersham Biosciences), and unincorporated
nucleotides were removed through a G-50 desalting spin column. The
membrane was baked for 2 h at 80 °C prior to prehybridization. The
hybridization procedures were performed in the presence of 32P-labeled
ADRP cDNA probe in Ultrahyb solution (Ambion) at 42 °C. ADRP
mRNA bands were detected by autoradiography.
Immunoprecipitation—Cells grown in 60-mm diameter dishes were
washed twice with PBS buffer and lysed in 1 ml of cold RIPA lysis buffer
(50mMTris-HCl, pH 7.5, 150mMNaCl, 1%Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS, and 2 mM EDTA) with proteases inhibitors (2
mM phenylmethylsulfonyl fluoride, 2 g/ml ALLN, 2 g/ml leupeptin,
and 2g/ml aprotinin). After addition of the lysis buffer, the disheswere
incubated on ice for 20 min. The cell lysates were centrifuged at 13,000
rpm at 4 °C for 20 min to pellet cell debris. The supernatant was trans-
ferred to a new tube and precleared with 30 l of agarose-protein A/G
plus mixture for 1 h at 4 °C. The immunoprecipitation reaction was
performed at 4 °C for 2 h on a rotator in 1 ml of the precleared super-
natant upon addition of rabbit anti-ADRP antibody at 1:500 or rabbit
anti-ubiquitin at 1:200 and 30 l of agarose-protein A/G plus mixture.
Rabbit polyclonal serum against hormone-sensitive lipase or rabbit pre-
immune serum was used as the negative control. The immunoprecipi-
tated complex was pelleted by centrifugation at 5000 rpm at 4 °C for 5
min, washed four times with cold RIPA buffer, and finally mixed with
sample buffer containing 4% SDS and 10 mM dithiothreitol. After boil-
ing at 100 °C for 5 min, proteins in the samples were loaded and sepa-
rated by SDS-PAGE. For pulse-chase experiments, [35S]methionine-
labeled ADRP in immunoprecipitates was detected directly by
autoradiography after separation by SDS-PAGE and exposure of the
dried gel to X-film for 24 h. For subsequent immunoblot analysis, the
immunoprecipitated proteins were separated on SDS-PAGE and trans-
ferred to nitrocellulose membrane followed by immunoblotting with
the antibodies against ADRP or ubiquitin, respectively.
Pulse-Chase Experiments—Cells were grown to 90% confluence in
60-mm diameter dishes and preincubated for 30 min in methionine-
free 10% FCS-DMEM to deplete cold methionine from the cells. The
cells were washed once with PBS and then pulse-labeled for 5 h with 0.1
mCi/ml [35S]methionine in warmedmethionine-free DMEM-10% FCS.
Pulse-labeling reaction was terminated by the addition of a 1,000-fold
excess of cold methionine. After one wash with PBS, cells were subse-
quently chased for 0 or 5 h in serum-free F12 culture medium in the
presence or absence of 400M oleic acid or 10MMG132 as indicated.
The [35S]methionine-labeled ADRP reached its maximum level at the
end point of labeling and then declined continually during chase. At the
end point of the chase, the chase medium was removed, and the cells
were washed once with PBS and lysed in 1 ml of cold RIPA buffer.
[35S]Methionine-labeled ADRP was immunoprecipitated with rabbit
anti-ADRP antibodies and then separated by SDS-PAGE and detected
by autoradiography. The density of bands was quantified by densitom-
etry and analyzed using the NIH Image program.
Immunofluorescence and Confocal Imaging—Cells were treated in
glass slide chambers and fixed for 15 min with 3% paraformaldehyde
and 0.1% Triton X-100 in PBS buffer at room temperature followed by
three washes for 10 min each with PBS. Nonspecific binding sites in the
cells were blockedwith 2%donkey serum for 30–60min andwashed for
three times for 5 min each. The cells were incubated with rabbit poly-
clonal serum against ADRP at 1:500 overnight at 4 °C and subsequently
with fluorescein isothiocyanate-conjugated donkey anti rabbit IgG at
1:100 for 1 h in the dark at room temperature (17). Intracellular lipid
storage droplets were easily visible under Nomarski optics/differential
interference contrast, and the immunofluorescent signal of ADRP was
observed using a Zeiss SCM510 confocal microscope.
Quantification of Total Triacyglycerols—Cells grown in 6-well plates
were treated with or without 2.5 M MG132 for 24 h, rinsed with PBS
buffer, and scraped into extraction buffer containing 20 mM Tris-HCl,
pH 7.4, and 1 mM EDTA. The cells were lysed with three freeze-thaw
cycles, and total lipids were extracted with chloroform and methanol
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(2:1) as described previously (36). Themass of total triacylglycerols from
triplicate samples was measured by OD at 340 nm using a commercial
kit (Sigma) andnormalized to total cellular protein contentmeasured by
the bicinchoninic acid method (Pierce).
Differentiation of 3T3-L1 Adipocytes—3T3-L1 (ATCC) fibroblastic
cells (preadipocytes) were grown to confluence in 12-well plate and
maintained for another 24 h in DMEM containing 10% FCS. The con-
fluent 3T3-L1 cells (day 0) were differentiated for 3 days in 10% FCS-
DMEM containing 0.5 mM IBMX (3-isobutyl-1-methyl-xanthine), 10
M dexamethasone, 1 g/ml insulin, and 8 g/ml biotin. The differen-
tiationmediumwas changed daily, and replacedwith regularmedium at
day 3 after initiating the differentiation program. The differentiated
3T3-L1 adipocytes weremaintained in fresh 10% FCS-DMEM. At day 8
of differentiation, the 3T3-L1 adipocyteswere treated for 18 hwith 5M
MG132.
Statistical Analysis—Data are expressed as the means S.E. A one-
way analysis of variance Tukey’s test was performed for statistical anal-
ysis using GraphPad Prism version 4.0, and p values  0.05 were con-
sidered statistically significant.
RESULTS
Fatty Acid Loading Promotes Intracellular Lipid Droplet Formation
and ADRP Accumulation—We showed previously that CHO cells cul-
tured with the free fatty acid oleic acid (OA) increased TAG storage,
with little deposition of OA into other lipid fractions (20). To determine
whether these growth conditions additionally altered the expression of
ADRP, we cultured CHO cells for 48 h in the absence or presence of 400
MOA and assessed ADRP protein levels by immunofluorescent imag-
ing and confocal microscopy as well as by immunoblotting. Relatively
few and tiny lipid droplets (Fig. 1A) were present in CHO cells cultured
in the absence of OA. After incubation for 48 h with 400 M OA, both
the number and size of the intracellular lipid storage droplets were
significantly increased. We also observed enhanced ADRP immunoflu-
orescence associated with the lipid droplets in cells cultured with OA
(Fig. 1A). Increased ADRP protein expression was confirmed by immu-
noblot analysis (Fig. 1B). Increases in intracellular lipid droplet storage
and ADRP accumulation were observed by 12 h after the loading with
OA (data not shown). Thus, increases in ADRP protein accumulation
paralleled the increase in neutral lipid deposition.
Delipidation Induces Down-regulation of ADRP by a Process Blocked
by Proteasomal Inhibitors—Delipidation of serum removes lipid pre-
cursors and deprives cells of fatty acid precursors that are required for
lipid droplet accumulation (9). Results from Fig. 1 indicate that ADRP
protein accumulation was promoted by the increase in intracellular
lipid storage. We were interested to determine whether ADRP protein
levels would be reduced upon the removal of lipid precursors from the
culture media. To enhance ADRP detection, we utilized CHO cells that
express ADRP from an adenovirus vector. The linkage of lipid deposi-
tion and ADRP expression is highlighted in Fig. 2A. Incubation of the
cells for 24 h in culture medium containing 10% calf serum that had
been delipidated with charcoal led to a substantial decrease of ADRP
protein in comparison with nondelipidated control cells. By contrast,
culturing cells in delipidated medium that was supplemented with 400
M oleic acid prevented the decline in ADRP protein (Fig. 2A). Thus,
ADRP appears to be degraded when TAG accumulation is inhibited. To
determine whether proteasomal activity is involved in ADRP degrada-
tion, we treated the cells with MG132, a specific inhibitor of the 26 S
proteasome. Clearly, MG132 promoted ADRP accumulation in cells
deprived of lipid precursors (Fig. 2A). Moreover, under nondelipidation
conditions, we observed that MG132 elevated ADRP protein in a con-
centration-dependent manner (Fig. 2B). The MG132-stabilizing effect
was evident at 0.625MMG132 andmaximal at2M (Fig. 2B). These
results provide strong support that ADRP is degraded through a protea-
somal pathway.
We investigated the effects of ADRP degradation using a series of
protease inhibitors (37). It has been well established that MG132 spe-
cifically inhibits the 26 S proteasome and that lactacystin is specific for
the 20 S proteasome (37, 38). ALLN is an inhibitor of both the 20 S and
26 S proteasomes and a partial inhibitor of the calpain protease. Calpep-
tin is specific for calpain, leupeptin inhibits trypsin-like and cysteine
proteases, and chloroquine and NH4Cl are lysosomal protease inhibi-
tors. As shown in Fig. 3A, addition of the three proteasome-specific
inhibitors, MG132, lactacystin, and ALLN, significantly increased
FIGURE1.Oleicacid increases intracellular lipidstoragedropletsandelevatesADRP
protein levels in CHOcells.A, CHO cellswere grown for 48 h in the absence or presence
of 400 M oleic acid. The cells were immunostained with rabbit -ADRP antibody and
fluorescein isothiocyanate-conjugated secondantibodyand imagedby fluorescent con-
focal microscopy. Intracellular lipid storage droplets were visible under Nomarski inter-
ference optics, and ADRP (arrowheads) appeared in association with the lipid droplets.
Note that incubationwith oleic acid elevates intracellular lipid droplets and fluorescence
of ADRP. Bars represent 10 m. B, immunoblotting with -ADRP antibodies was per-
formed after CHO cells were incubated for 48 h with or without 400M oleic acid. A and
B are representative of at least five separate experiments.
FIGURE 2.Delipidated culture serum leads to a decrease in ADRP protein by a proc-
ess prevented by the proteasome inhibitor MG132. A, CHO cells transfected with
Ad-ADRP were incubated for 24 h in normal or delipidated medium (Delipid.) with or
without 400 M oleic acid or with 5 M MG132. MG132 was administrated at 6 h after
transfer to delipidated medium and maintained for 18 h. Immunoblotting was per-
formed using -ADRP antibody. B, CHO cells transfectedwith Ad-ADRPwere cultured in
F12 medium supplemented with 10% normal calf serum and treated for 18 h with vary-
ing concentrations ofMG132 as indicated. The blots shown inA and B are representative
of three separate experiments.
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ADRP levels after treatment for 18 h. By contrast, the other protease
inhibitors were ineffective in increasing ADRP protein levels (Fig. 3A).
These data indicate that ADRP can be degraded through the protea-
some pathway.
We also examined whether proteasomal inhibitors increase ADRP
protein indirectly by elevating ADRP mRNA levels. Although addition
of 5 M MG132 for 18 h significantly increased ADRP protein levels,
addition of this agent did not alter ADRPmRNA levels under the same
conditions (Fig. 3B). Thus, the proteasome inhibitors elevated ADRP
protein by a post-transcriptional mechanism.
Proteasomal Degradation of ADRP—To examine ADRP turnover
more directly, we performed pulse-chase experiments. Cells were
labeled for 5 h with [35S]methionine followed by a 5-h chase in the
presence of unlabeledmethioninewith or without 10MMG132 or 400
Moleic acid. 35S-LabeledADRPwas immunoprecipitated anddetected
by autoradiography.More than 50%of the labeledADRPwas lost during
the 5-h control chase (Fig. 4, A and B). The specific proteasome inhibi-
tors MG132 (Fig. 4A,B), lactacystin, and ALLN (data not shown),
strongly (85%) preserved the labeled ADRP during the chase period
(Fig. 4,A and B), whereas calpeptin, leupeptin, chloroquine, and NH4Cl
had no effect on ADRP degradation (data not shown). These results
confirmed that degradation of ADRP was specifically mediated by the
proteasomal pathway. The addition of oleic acid only modestly blunted
the loss of the 35S-labeled ADRP (Fig. 4, A and B).
We also examined the effects of MG132 and oleic acid treatment on
the stabilization of total cellular (i.e. lipid-droplet associated) ADRP
following the removal of TAG precursors from the cell media (see Fig.
2). In contrast to the differing effects on newly synthesized ADRP, both
MG132 and exogenous oleic acid fatty acid efficiently “preserved” total
levels of ADRP protein during a similar time course as compared with
cells cultured in the absence of lipid precursors (Fig. 4C). These results
suggest that ADRP may be stabilized by a co-translational association
with lipid droplets, whereas unassociated ADRP is preferentially sub-
jected to proteasomal degradation.
Growth of Cells in the Presence of Fatty Acids Attenuates ADRP
Polyubiquitination—Proteins that are targeted for proteasomal degra-
dation are generally conjugated with polyubiquitin chains, forming the
high molecular weight complexes that are delivered to proteasomes for
further processing (38). Proteasome inhibitors do not prevent ubiquiti-
nation but block the ubiquitinated proteins from attaching to protea-
some particles. We treated cells for 24 h with or without 10 MMG132
or 10 M lactacystin and performed immunoprecipitation using anti-
body against ubiquitin followed by immunoblotting with antibody
against ADRP (Fig. 5A). In addition, ADRP was immunoprecipitated
with -ADRP and subsequently immunoblotted with -ubiquitin (Fig.
5B). In both cases, polyubiquitin-conjugated ADRP complexes were
detected as typically broad patterns from cells treated with MG132 or
lactacystin (Fig. 5, A and B). Such immunoprecipitates were not recog-
nized with rabbit preimmune serum or with rabbit polyclonal antibody
against hormone-sensitive lipase, both of which served as negative con-
trols (data not shown). Clearly, these results demonstrated that ADRP
was conjugated with polyubiquitin prior to degradation by the protea-
somes. Direct immunoblotting with -ADRP (Fig. 5C) showed the
appearance of several extra bands upon incubation with 10 MMG132
for 24 h, which likely reflects polyubiquitinated ADRP. Such polyubiq-
uitination was dramatically attenuated in the presence of oleic acid (Fig.
FIGURE 3. Proteasome inhibitors specifically increase ADRP protein accumulation
without alteringADRPmRNA transcript levels.A, CHO cells were treated for 18 hwith
different protease inhibitors. After lysis, 50 g of whole cell protein was separated by
SDS-PAGE and immunoblotted using -ADRP antibody and horseradish peroxidase-
conjugated secondantibody. The reagents usedwere: 10MMG132, 5M lactacystin, 50
M ALLN, 25 M calpeptin, 25 M leupeptin, 2.5 mM NH4Cl, and 100 M chloroquine. B,
CHO cells were treatedwith or without 5MMG132 for 18 h and harvested for immuno-
blotting and northern blotting. Top panel, immunoblot of ADRP protein; middle panel,
Northern blot of ADRP RNA; bottom panel, 28 S rRNA control. Blots shown are represent-
ative of three separate experiments.
FIGURE 4. Effects of MG132 and oleic acid on
ADRP protein stability. A, CHO cells transfected
with Ad-ADRP were pulse-labeled for 5 h with
[35S]methionine and chased for 5 h in serum-free
medium in the absence or presence of 10 M
MG132 or 400M oleic acid. 35S-labeled ADRPwas
immunoprecipitated (IP) using-ADRP antibodies
and detected by autoradiography. The image
shown is representative of four separate experi-
ments. B, densitometry analysis of A. The values
are presented as percentage of 35S-labeled ADRP
prior to chase (means  S.E.) from four separate
experiments. C, CHO cells transfected with
Ad-ADRP were grown for 5 h and transferred to
delipidatedmedium in the absence or presence of
10MMG132or 400Moleic acid. Total ADRPpro-
tein was examined by immunoblotting (IB) with
-ADRP antibodies. The blot shown is three sepa-
rate experiments.
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5C, bottom) suggesting that lipid droplet stabilization of ADRP reduces
ubiquitination.
Elevation of ADRP Accumulation by MG132 Is Associated with an
Increase in Total Cellular Triacylglycerols—Wehave demonstrated that
ADRP protein levels are regulated by the cellular capacity to store
TAGs. We thus sought to determine whether, reciprocally, the up-reg-
ulation of ADRP promoted intracellular lipid storage. Treatment with
MG132 greatly increased ADRP protein levels and the cellular immu-
nofluorescence of ADRP (Fig. 6). We also noticed a change from the
specific association of ADRP with intracellular lipid droplets to a wider
distribution throughout the cytosol. This broad distributionmay reflect
the association of ADRP with very small lipid droplets, an increased
association with an elevated pool of intracellular of fatty acids (25, 27),
or the accumulation of unassociated, polyubiquitinated ADRP. How-
ever we observed that cells that were treated with 2.5 M MG132 for
24 h (Fig. 7) and that possess elevated ADRP protein accumulated sig-
nificantly higher levels of total TAG (2.8-fold) as compared with
untreated controls. Thus, increasing ADRP protein by inhibiting its
degradation may promote intracellular TAG synthesis, data that are
consistent with observations that link ADRP and lipid accumulation
(30).
Disappearance of ADRP Protein during the Differentiation of 3T3-L1
Adipocytes Is Mediated by Proteasomal Degradation—ADRP mRNA
expression is up-regulated early during differentiation of 3T3-L1
adipocytes (39). Shortly thereafter perilipin gene expression is
induced, and the intracellular lipid droplets acquire a coating of
perilipin. Although ADRPmRNA levels remain elevated, ADRP pro-
tein is no longer detected (9). We speculated that perilipin associa-
tion with lipid droplets precludes the binding of ADRP, thus promot-
ing its proteasomal degradation. To test this hypothesis, we added
the specific proteasome inhibitor MG132 to differentiating 3T3-L1
adipocytes at day 8 of differentiation, a time when perilipin expres-
sion is elevated and ADRP protein has disappeared (Fig. 8). Clearly,
the proteasome inhibitor promoted the accumulation of ADRP pro-
tein in the maturing 3T3-L1 adipocytes (Fig. 8), indicating that the
disappearance of ADRP protein late during differentiation results
from proteasome-mediated degradation.
DISCUSSION
In the present study we show that exogenous oleic acid enhances
the accumulation of ADRP protein in CHO cells. This also promotes
the deposition of TAG in intracellular neutral lipid droplets, which
provide stabilization sites for ADRP association. Conversely, depri-
vation of fatty acids from the culture medium leads to a loss of ADRP,
a process antagonized by MG132, a specific proteasome inhibitor.
MG132 completely blocked the degradation of endogenous ADRP
without changing ADRP mRNA levels, suggesting a post-transla-
tional regulation of ADRP. Only proteasome-specific inhibitors pre-
vented ADRP degradation in either ADRP-overexpressing or native
FIGURE6. InhibitionofproteasomaldegradationwithMG132enhances the immun-
ofluorescent signal of ADRP and increases intracellular lipid droplet formation.
CHO-ADRP cells were treated for 18 h with or without 5MMG132. Immunofluorescent
staining was performed using antibody against ADRP. Top, control cells; bottom, 5 M
MG132. Bars represent 10 m in both panels. The picture shown is representative of at
least five separate experiments.
FIGURE 5. ADRP conjugation to ubiquitin is
attenuatedbyoleicacid.AandB, CHOcells trans-
fectedwith Ad-ADRPwere incubated for 24 hwith
or without 10 M MG132 or 10 M lactacystin
(Lact). Cellular lysates were prepared and immu-
noprecipitated (IP) using -ubiquitin (-Ub) anti-
bodies followed by immunoblotting (IB) with
-ADRP antibodies (A) or immunoprecipitated
using -ADRP antibodies followed by immuno-
blotting with -ubiquitin antibodies (B). C,
Ad-ADRP infected CHO cells were treated for 12 h
with or without MG132 at the indicated concen-
trations in the absence or presence of 400Moleic
acid. ADRP protein in the cell lysates was probed
with the antibodies against ADRP. The arrows indi-
cate presumptive polyubiquitinated ADRP; their
appearance was reduced by the addition of oleic
acid. All of the blots shown represent at least three
individual experiments.
FIGURE 7. Inhibition of proteasomal degradation of ADRP is accompanied with an
increase in total cellular triacylglycerols. CHO cells transfected with Ad-ADRP were
grown in 6-well plates treated with or without 2.5 M MG132 for 24 h. Total lipids were
extracted from cells with chloroform andmethanol and themass of total triacylglycerols
was measured in triplicate and normalized with total cellular protein content. Data are
presented as the means  S.E. of four separate experiments performed in triplicate. *,
p 0.02 compared with control.
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CHO cells. Protease inhibitors directed at alternate degradative pro-
cesses had no effect.7
In pulse-chase experiments, [35S]methionine-labeled ADRP reached
amaximum at the end of the pulse and then continually declined during
the chase period. Under these conditions, newly synthesized ADRP has
a half-life of2 h. This is in contrast to lipid droplet-associated perili-
pin, which has a half-life of nearly 12–24 h.8 MG132 significantly
blocked the loss of [35S]methionine-labeled ADRP, confirming that
ADRP is degraded through the proteasome pathway.
Polyubiquination is a step in targeting proteins for degradation by the
2000-kDa, ATP-dependent, 26 S proteasome complex. Ubiquitin is a
small peptide that marks proteins through a covalent bond between
glycine and lysine residues on the target protein. By regulating protein
degradation through ubiquitination, cells can quickly eliminate the
function of proteins in response to the changes in cellular environment
(33–35). Proteasomal inhibitors do not prevent ubiquitination but block
the binding of ubiquitinated proteins to proteasomes resulting in the
accumulation of polyubiquitinated proteins. These usually exhibit a
smear of high molecular mass by SDS-PAGE (37, 38). Deubiquitinating
enzymes serve to rescue ubiquitinated proteins from degradation (35).
As the amount of native ADRP is elevated upon addition of proteasome
inhibitors, we detected the co-immunoprecipitation of ADRP and ubiq-
uitin, confirming that ADRP is conjugated to polyubiquitin and targeted
for degradation.
We showed previously that fatty acid loading of Y-1 adrenal cortical
cells greatly increases perilipin protein without a corresponding
increase in perilipin mRNA (8). We speculated that the increase in
perilipin protein results from a post-translational stabilization of newly
synthesized perilipin by association with the stored neutral lipids. Sim-
ilarly, we reported that the addition of fatty acids to isolated rat lung
lipofibroblasts leads to a large increase in ADRP protein without a
change in ADRPmRNA (28), again suggesting post-translational regu-
lation of ADRP protein. Fatty acids are precursors for the intracellular
neutral lipid droplets that provide surface sites for ADRP binding (9).
The present study shows that delipidation of the serum deprives the
cells of fatty acid precursors. Under these conditions ADRP is degraded
by proteasomes. The addition of oleic acid increases TAGaccumulation
and dramatically attenuates the appearance of polyubiquitinatedADRP.
In 3T3-L1 adipocytes, ADRP protein is present early during differen-
tiation but disappears after the onset of perilipin expression, even in the
face of elevated ADRP mRNA expression (9). Recent studies have
revealed that ADRP and perilipin compete for space on the lipid droplet
surface.We surmise that intracellular lipid droplets have limited surface
space to bind either perilipin or ADRP. Perilipin attachment thus pre-
cludes the association of ADRP with the droplets (20, 40). Now we have
demonstrated that as perilipin protein prevails in mature 3T3-L1 adi-
pocytes, ADRP protein is degraded by proteasomes. ADRP stability can
be preserved by proteasomal-specific inhibition. Thus, proteasomal
degradation of ADRP under a variety of conditions in either fibroblasts
or adipocytes is an essential mode of regulation. In additional experi-
ments, we found that perilipin is also degraded by proteasomes, as evi-
denced by its ubiquitination and protection by proteasomal-specific
inhibitors.9 The regulation of lipid-associated proteins by the ubiquitin/
proteasome pathway is not limited to the PAT family. Apolipoprotein B,
which is co-translationally inserted into nascent lipoproteins, is also
degraded by proteasomes in the absence of adequate lipid products
(41–46). Similarly, lipoprotein A (47) and apolipoprotein E (48) are
subject to proteasomal degradation. This regulatory pathway may be a
common mode for modulation of lipid-associated proteins.
It has been reported that ADRP is able to bind stochiometrically to
fatty acids and to transport long chain fatty acid into cells (25, 27). As a
specific marker of lipid accumulation, ADRP is also proposed to play a
role in the formation of intracellular lipid droplets (23, 29, 30). Inhibi-
tion of ADRP degradation with MG132 leads to enhanced ADRP asso-
ciation with lipid droplets and, suprisingly, increased ADRP in the
cytosol. This increased cytosolic ADRP may represent an increase in
lipid droplets (25, 27) or, alternatively, accumulation of polyubiquinated
ADRP that does not associate with droplets. Currently there is no
method of distinguishing between the intracellular localization of native
ADRP and its ubiquitinated species, but we have demonstrated a 2.8-
fold elevation of total TAG in the cells that possess increased ADRP
upon the inhibition of proteasomal degradation. This suggests a role for
ADRP to facilitate intracellular TAG synthesis and lipid accumulation.
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